Ignova GmbH
Records under this name other than patents Ignova GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Ignova GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,261,095 | Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,913,904 | Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists Formerly held Lapsed on the fee record Ended Mar 13, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 13, 2026 | From the USPTO record |
| US 9,801,938 | Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists Formerly held Lapsed on the fee record Ended Oct 31, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 31, 2025 | From the USPTO record |